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Abstract
Background: Transplantation of neural stem/progenitor cells is a promising approach toward
functional restoration of the damaged neural tissue, but the injured spinal cord has been shown to
be an adverse environment for the survival, migration, and differentiation of the donor cells. To
improve the efficiency of cell replacement therapy, cell autonomous factors in the donor cells
should be optimized. In light of recent findings that Rho family GTPases regulate stem cell functions,
genetic manipulation of Rho GTPases can potentially control phenotypes of transplanted cells.
Therefore we expressed mutant forms of Rho GTPases, Rac, Rho, and Cdc42, in the neural stem/
progenitor cells and examined their survival and migration after transplantation.
Results: Manipulation of the individual Rho GTPases showed differential effects on survival, with
little variation in their migratory route and predominant differentiation into the oligodendroglial
lineage. Combined suppression of both Rac and Rho activity had a prominent effect on promoting
survival, consistent with its highly protective effect on drug-induced apoptosis in culture.
Conclusion: Manipulation of Rac and Rho activities fully rescued suppression of cell survival
induced by the spinal cord injury. Our results indicate that precise regulation of cell autonomous
factors within the donor cells can ameliorate the detrimental environment created by the injury.
Background
Neural stem/progenitor cells (NSPCs) are widely present
in the developing mammalian central nervous system
(CNS) and known for their capability of self-renewal and
potential of differentiation into multicellular lineages
[1,2]. The protocols of in vitro differentiation and mainte-
nance of NSPCs have been established [3,4], and trans-
plantation of NSPCs is thought to be an important
approach toward functional restoration of the damaged
CNS tissue, including injured spinal cords [5-7]. Previous
studies have shown partial functional improvement after
spinal cord injury by transplantation of NSPCs derived
from the embryonic CNS or embryonic stem cells [8-11].
Although these results suggested the potential of NSPC
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transplantation in the improvement of spinal cord func-
tion, there have been a small number of reports on basic
mechanisms of NSPC survival in the host spinal cord
environment. Previous studies have shown that the
injured spinal cord is not a favorable environment for the
survival, migration, and differentiation of the donor cells
[12,13]. Therefore, identification of regulatory mecha-
nisms of NSPC survival and differentiation both in the
intact and injured spinal cord environment should be
important.
The Rho family small GTPases, members of the Ras super-
family, are known to regulate cell shape, movement, and
adhesion in multiple mammalian cell types [14]. Rho
GTPases also have been demonstrated to activate a
number of signal transduction pathways involved in cell
cycle progression, gene expression, and cell survival [15].
In the context of development and maintenance of neu-
rons and glial cells in the CNS, negative roles of Rho fam-
ily GTPases in cell survival have been implicated. For
example, Rac/Cdc42 GTPases promote the apoptotic
death of NGF-deprived sympathetic neurons [16,17] and
activation of Rac by p75 neurotrophin receptor (p75NTR)
induces apoptosis via activation of c-jun N-terminal
kinase (JNK) in oligodendrocytes [18]. Rho activation is
prominently enhanced in the injured spinal cord and
involved in p75NTR-dependent apoptosis [19]. These
experimental evidences suggest negative roles of Rho
GTPase in survival of transplanted NSPCs in an adverse
microenvironment of the injured spinal cord.
In this study we identified Rho and Rac GTPase activity as
a potent regulator of cell survival after NSPC transplanta-
tion. Recombinant adenovirus-mediated expression of
dominant-negative forms of RhoA and Rac1 increased the
survival of transplanted cells more then two-fold in the
intact spinal cord. Furthermore, expression of RhoDN and
RacDN in NSPCs fully rescued down-regulation of cell
survival after the transection of spinal cords. Taken
together with strong protective effects of the same genetic
manipulation against chemically induced apoptosis in
vitro, these results indicate that Rho GTPase is one of the
critical cell- autonomous factors promoting successful
integration and survival of NSPCs in the injured spinal
cord.
Results
Suppression of NSPC survival in the injured spinal cord 
environment
Our previous study of NSPC transplantation into the
intact spinal cord indicated advantage of using hippocam-
pus-derived NSPCs as a donor source in comparison with
spinal cord-derived NSPCs [20]. Additionally, hippocam-
pus-derived NSPCs showed more preferential migration
toward the white matter of the host spinal cord. This pref-
erential association with the white matter and directed
differentiation of NSPCs toward the oligodendroglial lin-
eage are advantageous in facilitating remyelination in the
injured spinal cord.
In this study, we first examined whether hippocampus-
derived NSPCs show similar survival and migratory
behavior in the injured spinal cord. We utilized complete
transection of the neonatal spinal cord as a model of the
spinal cord injury. In this injury model, the location and
extent of the lesion can be precisely controlled. We gener-
ated complete transection of the spinal cord at the level of
T9-10 on postnatal day 7. Transplantation of hippocam-
pus-derived NSPCs expressing GFP was performed on
postnatal day 14 at the level of T8-9. As a control, we
introduced GFP-expressing NSPCs into the intact spinal
cords of 14-day-old pups. Transduction of reporter genes
by using recombinant adenoviruses was highly efficient,
with more than 85% of NSPCs judged to be GFP-positive
by fluorescence-activated cell sorting (FACS; data not
shown). The extent of survival and migratory behavior in
both groups 7 days after transplantation were analyzed by
using immunofluorescence detection of transplanted cells
with anti-GFP antibody staining (n = 6 for the injured spi-
nal cord, n = 8 for the control). In both intact and injured
environments, engrafted cells were detected at the original
injection sites (Figure 1A and 1B). The cells at the injec-
tion sites were clearly separated from the sites of transec-
tion in all samples examined, indicating successful
placement of NSPCs at the sites away from the transection
level (Figure 1B). In both experimental conditions, trans-
planted cells were preferentially localized to the dorsal
white matter (Figure 1B). We noticed less GFP-positive
cells in the injured spinal cords and this observation was
confirmed by counting the total number of transplanted
cells (Figure 1C; control;481.9 ± 173.3 cells, injured;
179.7 ± 28.6 cells, mean ± SEM for all the data, t-test p <
0.05). The transplanted cells also showed less migratory
behavior in the injured environment. Indeed, the distribu-
tion of GFP-positive cells in each 500 μm segment of the
white matter along the rostrocaudal axis was statistically
different and more transplanted cells were localized near
the injection sites in the injured spinal cords (Figure 1D;
Mann-Whitney-U test, P < 0.05). These results indicate an
adverse environment of injured spinal cord for both sur-
vival and migration of hippocampus-derived NSPCs.
Genetic manipulation of Rho family GTPases in NSPCs
The less favorable environment of the injured spinal cord
will seriously impair neural tissue replacement therapy
after spinal cord injury. One possible approach toward
overcoming this difficulty is to genetically modify the
donor NSPCs to be less vulnerable to the host environ-
ment. Toward this goal, we next evaluated the possibility
of manipulating the activity of multiple Rho GTPasesMolecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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Transplantation of NSPCs into the injured spinal cord Figure 1
Transplantation of NSPCs into the injured spinal cord. (A) Montages of confocal microscopic images of the intact and 
injured spinal cords immunostained with anti-GFP antibody to detect the distribution of the transplanted NSPCs. The sites of 
spinal cord transection (arrowhead) are clearly separated from the sites of transplantation of NSPCs (arrows). The fixed spinal 
cord sections were stained with both anti-GFP antibody (green) and anti-neurofilament-200 antibody (red). Bar, 200 μm. (B) 
Numbers of surviving cells 7 days after transplantation in the white and gray matter. Single sections containing the highest 
number of GFP-positive cells were selected and the total numbers of surviving cells in these sections were taken as a represen-
tation of the extent of surviving cells. In both the intact and injured spinal cords, there was a preference of transplanted cells to 
reside within the white matter (intact gray matter; 83.4 ± 28.9 cells, intact white matter; 398.5 ± 151.5 cells, t-test p < 0.05, 
injured gray matter; 8.2 ± 2.8 cells, injured white matter; 171.5 ± 28.5 cells, t-test p < 0.05). (C) Numbers of surviving cells 7 
days after transplantation in the total area of the spinal cord sections. The difference between injured and intact spinal cords 
was statistically significant (intact; 481.9 ± 173.3 cells, injured; 179.7 ± 28.6 cells, t-test p < 0.05). (D) Normalized rostrocaudal 
distribution of transplanted cells in the intact and injured spinal cords. The proportion of transplanted cell numbers in each 500 
μm section along the rostrocaudal axis was plotted. The difference of the cell distribution was statistically significant (Mann-
Whitney-U test, p < 0.05).Molecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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(RhoA. Rac1, and Cdc42) in NSPCs. Rho GTPases have
been shown to be critically involved in both survival and
migration of a variety of cell types. Therefore optimization
of the levels of activities in Rho family GTPases can poten-
tially influences the survival and migration of NSPCs in
the context of spinal cord transplantation.
NSPCs derived from rat embryonic hippocampus were
maintained in the presence of bFGF. They were trans-
fected with recombinant adenoviruses to express constitu-
tive active (CA) or dominant negative (DN) forms of
RhoA, Rac1, or Cdc42 under the control of the CAG pro-
moter, along with marker genes (β-galactosidase for CA
and GFP for DN, Figure 2A). Efficient expression of β-
galactosidase or GFP in progenitors was observed two
days after infection (Figure 2B and 2C). Immunoblotting
using antibodies against RhoA, Rac1, or Cdc42 revealed
overexpression of both CA and DN forms of individual
Rho family GTPases in comparison with uninfected
NSPCs (data not shown). We observed extensive overlap
of cells immunopositive with neural stem cell marker nes-
tin and cells expressing β-galactosidase or GFP, suggesting
efficient gene transduction into the NSPC population
(Figure 2B and 2C). Adenoviral infection itself did not
have any deteriorative effects on both cell morphology
and viability. To see if infected cells show normal differen-
tiation phenotype, we quantified the numbers of cells
immunopositive with anti-MAP2, anti-GFAP, and anti-
RIP after differentiation of cells by bFGF withdrawal
(Additional file 1). The fractions of differentiated cell
types were not statistically different from those of control
cells without recombinant adenovirus infection.
Survival of NSPCs expressing Rho family GTPase mutants 
in the intact spinal cord
NSPCs genetically modified by recombinant adenoviruses
expressing Rho GTPase mutants were grafted into intact
spinal cords of 7 day-old rat pups. Data from 6 cases of
control LacZ-expressing cells, 12 cases of control GFP-
expressing cells, 5 cases of CdcCA-expressing cells, 11
cases of CdcDN-expressing cells, 12 cases of RacCA-
expressing cells, 11 cases of RacDN-expressing cells, 10
cases of RhoCA-expressing cells, and 13 cases of RhoDN-
expressing cells (80 cases in total) were analyzed in this
study. We could detect donor cells in the host spinal cord
7 days after transplantation in all samples except those
that received transplantation of cells expressing RhoCA.
Absence of RhoCA-expressing donor cells in the intact spi-
nal cord suggested negative effect of Rho activity in sur-
vival of transplanted NSPCs.
To more precisely evaluate the effects of manipulating the
activity of Rho family GTPases, we measured the extent of
cell survival by counting the numbers of transplanted cells
marked with either β-galactosidase or GFP in representa-
tive histological sections containing the highest number
of immunopositive cells (Figure 3A). Our previous analy-
sis of transplanted NSPCs indicated little mitotic activity
of NSPCs after transplantation. Therefore, a decrease in
the number of cells surviving 7 days after transplantation
mainly reflects the extent of cell death in the host environ-
ment. Transplantation of cells expressing β-galactosidase
or GFP showed similar numbers of surviving cells, con-
firming similar detection sensitivity of the two markers
and the reproducibility of our transplantation experi-
ments. As already mentioned, we could not detect RhoCA-
expressing cells in the sections, suggesting strong negative
effects of RhoA activity in cell survival. Suppression of Rho
activity by the DN construct, however, did not enhance
donor cell survival, suggesting that the endogenous Rho
activity in the transplanted cells does not play a major role
in cell survival. Increase of Rac activity by RacCA results in
similar, but milder reduction of the cell number. Impor-
tantly, suppression of Rac activity in transplanted cells by
RacDN significantly enhanced the cell survival (139.4% of
the control, ANOVA, p < 0.05). This result suggests the
importance of endogenous activity of Rac in induction of
cell death in NSPCs after transplantation. Cells expressing
either CdcCA or CdcDN showed reduction in surviving
cell numbers. Collectively, these results indicate differen-
tial effects of individual members of Rho family GTPases
in survival of NSPCs after transplantation into the host
spinal cord.
Down regulation of RhoA activity alone did not enhance
survival of transplanted cells in our experiments. How-
ever, a previous report indicated that in the injured spinal
cord, endogenous neurons and glial cells show Rho acti-
vation at the lesion sites and pharmacological prevention
of Rho activation facilitates cell survival [19,21]. To fur-
ther illustrate possible involvement of Rho activation in
cell survival after transplantation, we generated NSPCs
expressing both RacDN and RhoDN and characterized the
survival of double positive cells 7 days after transplanta-
tion into the intact spinal cord. Microscopic examination
and cell counting of representative single sections from
each transplanted specimens revealed significant
enhancement of cell survival (Figure 3A, ANOVA, p <
0.01). To more rigorously measure the extent of enhance-
ment in cell survival, we counted the number of GFP-pos-
itive cells present in the complete sets of serial sections
prepared from the spinal cords transplanted with either
RacDN/RhoDN double positive cells (n = 5) or control
cells expressing GFP (n = 5). On average, 6439 cells were
present in all section (minimum number of cells (Nmin)
= 3450, maximum number of cells (Nmax) = 9621) after
transplantation of RacDN/RhoDN double positive
NSPCs, and 2565 GFP-positive cells (Nmin = 434, Nmax
= 3796) after transplantation of control cells (Figure 3B).
However, the numbers of consecutive sections containingMolecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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GFP-positive cells within the complete sets of serial sec-
tions were similar (8.2 sections on average with a range
from 7 to 9 sections in transplantation of control cells, 7.8
sections on average with a range from 6 to 9 sections in
transplantation experiments with RacDN/RhoDN double
positive cells). Thus we obtained 2.5-fold increase of sur-
viving cells after transplantation by modulating Rho fam-
ily GTPase activity, albeit a similar extent of cell spreading
in the host spinal cord.
Expression of both RacDN and RhoDN may facilitate
long-term survival of transplanted NSPCs. To test this pos-
sibility, we analyzed the survival of transplanted NSPCs
three weeks after transplantation. There were a large
number of GFP-positive cells in the spinal cord three
weeks after transplantation and the level of GFP expres-
sion and morphology of these cells was comparable to
those one week after transplantation. The number of
transplanted cells in single histological sections with the
highest number of GFP-immunopositive cells was 791.6 ±
156.9 in the group of transplanting NSPCs expressing
both RacDN and RhoDN, which was significantly higher
than the value of the control (320.8 ± 80.4 cells per sec-
tion, p < 0.05, Figure 3C). There was 66% decline of the
surviving donor cells from one week to three weeks after
transplantation in the control condition (from 481.9 ±
173.3 cells to 320.8 ± 80.4 cells). However, expression of
both RacDN and RhoDN induced 2.5-fold increase of cell
survival even at this later stage, indicating long-lasting
effects of suppressing Rho family GTPases in the enhance-
ment of cell survival after transplantation.
Migration of NSPCs expressing Rho family GTPase 
mutants in the intact spinal cord
Enhancement of cell survival by expressing RacDN and
RhoDN is advantageous in neural tissue replacement ther-
apy. However, migratory and differentiation phenotypes
of the genetically manipulated cells should be examined
to confirm the absence of abnormality. Microscopic eval-
uation on the distribution of transplanted cells revealed a
similar pattern both in sagittal and coronal planes irre-
spective of the expressing Rho GTPase mutants except for
RhoCA, which eliminated all the NSPCs 7 days after trans-
plantation. Transplanted cells were distributed predomi-
nantly in the dorsal white matter and a small fraction of
cells were detected in the gray matter. This result is consist-
ent with our previous transplantation experiments of hip-
pocampus-derived progenitor cells [20]. Cell migration
from the injection sites was predominant along the rostr-
ocaudal axis, and was restricted in both dorsoventral axis
and mediolateral axis (Figure 4A, B, and 4C) in all cases of
transplantation experiments.
To further evaluate the migratory behavior, we divided the
host spinal cord into 500 μm segment along the rostro-
Expression of mutated Rho GTPases in NSPCs Figure 2
Expression of mutated Rho GTPases in NSPCs. (A) 
Design of expression constructs of recombinant adenovi-
ruses. DNA fragments coding three CA forms of Rho 
GTPases (G12V mutant of cdc42, G12V mutant of rac1, 
G14V mutant of rhoA) were placed under the control of a 
CAG promoter in combination with the reporter gene lacZ. 
DNA fragments coding three DN forms of Rho GTPases 
(T17N mutant of cdc42, T17N mutant of rac1, T19N mutant 
of rhoA) were also placed under the control of a CAG pro-
moter in combination with the reporter gene GFP. Interven-
ing internal ribosomal entry sites (IRES) support the 
expression of reporter genes lacZ and GFP in these con-
structs. (B and C) Infection of cultured NSPCs with recom-
binant adenoviruses of CA forms (B) or DN forms (C) of 
Rho GTPases. Nestin-positive NSPCs expressed comparative 
amounts of β-galactosidase/GFP 2 days after infection. Bar, 
20 μm.Molecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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caudal axis, and counted the numbers of β-galactosidase
or GFP-positive cells in each segments (Figure 5A). There
was no significant difference in cell distribution among
cells expressing different Rho GTPase mutants. In all cases
examined, transplanted cells migrated into the dorsal
white matter and the numbers of cells in the gray matter
were significantly low (Figure 5B). We also plotted the
profile of cell numbers along the rostrocaudal axis for cells
expressing different Rho GTPase mutants. Qualitatively
transplanted cells expressing different Rho GTPase
mutants showed similar migratory profiles with their peak
at the injection sites (Figure 5C-F). We then calculated the
average migratory distances of transplanted cells from the
injection sites. There was no significant difference in this
parameter (Figure 5G), confirming an unaltered migra-
tory phenotype of the cells with manipulated Rho GTPase
activity.
We demonstrated previously that the transplanted NSPCs
mainly differentiated into the oligodendroglial lineage
[20]. A double-label immunofluorescence study with
anti-GFP and anti-RIP (an oligodendrocyte marker) con-
firmed this trend in both control cells and cells expressing
Rho GTPase mutants. Especially, both RacDN and
RhoDN, which promoted survival of NSPCS, did not sup-
press differentiation of NSPCs into oligodendrocytes (Fig-
ure 5H). To estimate the extent of differentiation, we
measured the proportion of RIP-positive cells in total
GFP-positive cells and found no statistical difference
between the control condition (76.9 ± 1.8%) and the con-
dition of suppressing both Rac and Rho activities (76.2 ±
4.7%). The same proportions of CNPase -positive cells
were confirmed as another oligodendrocyte marker, and
the rest of RIP or CNPase positive cells in total GFP-posi-
tive cells were GFAP-positive cells. Quantitative analysis
revealed that 20.7 ± 0.7% of GFP-positive cells was immu-
nopositive for GFAP in control cells, and 23.7 ± 1.4% in
RacDN and RhoDN cells. Neither control cells nor RacDN
and RhoDN cells exhibited MAP2 expression in the host
spinal cords. There is no difference between control cells
and RacDN and RhoDN cells. Taken together, these
results indicate unaltered migratory and differentiation
capabilities of NSPCs after manipulation of Rho GTPase
activity.
Regulation of programmed cell death in vitro by 
manipulating Rho GTPase activity
Both pro-apoptotic and pro-survival effects of Rho family
GTPases have been reported in multiple types of cells in
the neural lineages [16,22]. Our transplantation experi-
ments suggested involvement of both Rho and Rac
GTPase activity in inhibiting cell survival in the host envi-
ronment. We next utilized an in vitro culture system of
NSPCs to evaluate the roles of Rho GTPases in the process
Transplantation of NSPCs expressing mutant forms of Rho  GTPases Figure 3
Transplantation of NSPCs expressing mutant forms 
of Rho GTPases. (A) Number of surviving cells in sections 
of spinal cords 7 days after transplantation. After transplanta-
tion of CA forms of cdc42 and rhoA, numbers of the surviv-
ing cells were significantly lower than the control cells 
expressing only lacZ (LacZ-positive control; 620.0 ± 90.9 
cells, CdcCA; 235.6 ± 38.5 cells (p < 0.05), RacCA; 317.3 ± 
60.5 cells, RhoCA; 0.0 cells (ANOVA, p < 0.01)). Although 
expression of the DN form of cdc42 reduced the number of 
surviving cells, expression of the DN form of rac1 increased 
the number of surviving cells (GFP-positive control; 723.3 ± 
117.6 cells, CdcDN; 232.8 ± 88.8 cells (p < 0.01), RacDN; 
1013.6 ± 39.7 cells (ANOVA, p < 0.05), RhoDN; 760.8 ± 
162.9 cells). Double infection of adenoviruses expressing 
RacDN and RhoDN further enhanced the survival of trans-
planted NSPCs (1258.5 ± 133.6 cells (ANOVA, p < 0.01 in 
comparison with two types of control conditions)). (B) 
Increase in the total number of surviving NSPCs by expres-
sion of DN forms of both Rac and Rho. Complete serial sec-
tions of the transplanted spinal cords were examined and the 
total numbers of GFP-positive cells in two conditions were 
counted. A significant increase in surviving cells was observed 
in the condition of infecting two DN forms of Rho GTPases 
(control; 2565.2 ± 583.9 cells, RhoDN and RacDN; 6439 ± 
990.6 cells, t-test p < 0.01). (C) Number of surviving cells in 
sections of spinal cords three weeks after transplantation. 
Double infection of adenoviruses expressing RacDN and 
RhoDN enhanced the survival of transplanted NSPCs 
(RacDN and RhoDN; 791.6 ± 156.9 cells, GFP-positive con-
trol; 320.8 ± 80.4 cells, t-test p < 0.05).Molecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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of programmed cell death induced by growth factor dep-
rivation. Withdrawal of bFGF from the NSPC culture
induced apoptosis in a small fraction of cells. Immunocy-
tochemistry using an antibody against the cleaved form of
caspase-3 detected the presence of activated caspase-3 in
the cytoplasm of cells showing typical morphology of
apoptotic cells. NSPCs genetically manipulated for their
activity of Rho GTPases showed distinct responses to the
withdrawal of bFGF (Figure 6A and 6B). Expression of
RhoCA significantly increased the number of cells immu-
nopositive with the activated caspase-3. Up-regulation of
Cdc42 activity results in a slight increase of apoptotic cell
number, which was not statistically significant. Both
RhoDN and RacDN did not enhance cell death after with-
drawal of bFGF. The overall pattern of promoting cell
death by individual Rho GTPase mutants is reversibly cor-
related with the extent of cell survival after transplantation
into the spinal cord (Figure 3A and Figure 6B), suggesting
that the underlying molecular pathway is identical in two
experimental paradigms.
Withdrawal of bFGF in NSPC cultures induced intrinsic
apoptotic cascades in a small population of cells. To eval-
uate the effects of suppressing Rho and Rac GTPase activ-
ity in a condition of inducing more extensive cell death,
we utilized the protein kinase inhibitor staurosporine.
Apoptotic cells were identified by their nuclear morphol-
ogy after staining with Hoechst dye, together with immu-
noreactivity against single-stranded-DNA (ssDNA) [23] or
cleaved from of caspase-3. Application of staurosporine
induced apoptosis in more than 10% of cells, which were
also immunoreactive with antibodies against activated
caspase-3 or ssDNA (Figure 7A). Suppression of both Rho
and Rac activity by recombinant adenovirus infection
reduced the induction of staurosporine-dependent apop-
tosis significantly (Figure 7B), suggesting strong pro-
apoptotic effects of both Rho and Rac activities after a dra-
matic alteration of the cell environment, such as trans-
plantation into the injured spinal cord.
Enhancement of cell survival in the injured spinal cord by 
manipulating Rho GTPase activity
Simultaneous suppression of Rac and Rho GTPase activi-
ties resulted in strong enhancement of cell survival both
in the intact spinal cord after transplantation and in the
culture system. We next analyzed if the manipulation of
Rho family GTPase activity can enhance the survival of
NSPCs in the injured spinal cord (Figure 8A and 8B). In
control transplantation experiments, we identified 179.7
± 28.6 GFP-positive cells (Nmin = 140, Nmax = 320) per
single sections of the spinal cord. When NSPCs expressing
both RacDN and RhoDN were transplanted, the number
of surviving cells (420.6 ± 72.2) was 2.3-fold higher than
the control condition and this difference was statistically
significant (GFP; n= 6, DN; n = 5, t-test p < 0.01). To esti-
mate the extent of differentiation, we measured the pro-
portions of RIP- and GFAP-positive cells in total GFP-
positive cells transplanted in the injured spinal cords.
Quantitative analysis revealed that 23.3 ± 1.4%, 50.4 ±
2.6% of total GFP cells and 24.5 ± 1.6%, 54.7 ± 2.8% of
the total RacDN and RhoDN cells were positive for RIP
and GFAP, respectively. There is no difference between
control cells and RacDN and RhoDN cells. Neither the
control cells nor the RacDN and RhoDN cells exhibited
MAP2 expression in the host spinal cords. Importantly,
the number of surviving cells was comparable to that of
transplanting wild-type cells into the intact spinal cord
Migration pattern of NSPCs expressing DN forms of both  Rho and Rac after transplantation into the intact spinal cords Figure 4
Migration pattern of NSPCs expressing DN forms of 
both Rho and Rac after transplantation into the 
intact spinal cords. (A) Distribution of the transplanted 
NSPCs expressing both RhoDN and RacDN at three differ-
ent levels of the spinal cord. The sections were immunos-
tained with specific markers for oligodendrocytes (RIP), 
neuronal axons (NF; neurofilament-200 antibody), and astro-
cytes (GFAP; anti-glial fibrillary acidic protein antibody). 
Transplanted cells are restricted to the dorsal white matter, 
where strong immunoreactivity of RIP and NFs was 
observed. Bar, 100 μm. (B and C) Rostrocaudal distribution 
of NSPCs expressing GFP (B) and LacZ (C) after spinal cord 
transplantation detected by immunostaining with anti-GFP 
antibody (B) or anti-β-galactosidase antibody (C). The dashed 
lines indicate the border between the white matter and the 
gray matter. Preferential localization of the immunoreactive 
cells in the white matter is evident. Bar, 200 μm.Molecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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(Figure 1C and Figure 8B). Thus the genetic manipulation
of Rho family GTPases can overcome the adverse host
environment induced by the spinal cord injury.
Discussion
In this study we identified Rho GTPase activity as a critical
regulator of cell survival in the paradigm of NSPC trans-
plantation into the rodent spinal cord. A less permissible
environment for the NSPC created by spinal cord transec-
tion induced pronounced reduction in cell survival after
transplantation. However, this reduction in cell survival
was fully mitigated by controlling the activity of two Rho
family GTPases, Rac and Rho.
We observed prominent reduction in the number of sur-
viving cells after NSPC transplantation into the injured
spinal cord. This adverse influence on cell survival can be
derived from inflammatory response of the host cells.
Tumor necrosis factor alpha (TNF-α) is a major cytokine
produced acutely in the injured spinal cord. TNF-α
Quantitative analysis of the migration pattern of NSPCs expressing mutant forms of Rho GTPases after transplantation Figure 5
Quantitative analysis of the migration pattern of NSPCs expressing mutant forms of Rho GTPases after trans-
plantation. (A) Schematic representation of the compartments defined by their distance from the injection site. Cells were 
grouped by their localization either within the white matter or the gray matter. Spinal cords were further subdivided into the 
proximal compartment, rostral distal compartment, and caudal distal compartment. The proximal compartment is the area 
within 250 μm from the injection sites. (B) Number of cells in the white matter or the gray matter. Preferential localization of 
transplanted cells in the white matter was observed in all NSPCs expressing CA or DN forms of Rho GTPases, except NSPCs 
expressing RhoCA. No surviving cells were detected in transplantation of NSPCs expressing RhoCA. (C-F) Migratory profiles 
of transplanted NSPCs expressing reporter genes (C) or mutant forms of Rho GTPases cdc42 (D), rac1 (E), and rhoA (F). In 
spite of the differences in the total number of surviving cells, the overall profiles of cell migration were similar in cells express-
ing mutant Rho GTPases. (G) Mean migratory distance of surviving NSPCs 7 days after transplantation. Cells expressing mutant 
forms of Rho GTPases showed a similar extent of migration along the rostrocaudal axis except for RhoCA. (H) Morphology 
and differentiated phenotype of transplanted cells expressing both RhoDN and RacDN. Ramified processes extended from the 
GFP-positive cell bodies and these structures were immunopositive with an oligodendrocyte marker RIP (arrows). Bar, 20 μm.Molecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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induces demyelination and oligodendrocyte death in
models of CNS injury [24,25]. Suppression of TNF-α pro-
duction in injured spinal cord by the elevation of cAMP
was shown to be correlated with functional recovery [26].
However, a previous study demonstrated rapid down-reg-
ulation of TNF-α transcripts in the injured spinal cord,
suggesting a less prominent role of TNF-α one week after
injury, when the expression level of TNF-a returned to the
level of the non-operated control tissue [27]. Another can-
didate preventing NSPC survival is p75NTR, which is also a
member of the TNF receptor family. In addition to its
function as a low-affinity receptor for NGF, p75NTR forms
a receptor complex together with Nogo-66 receptor and
LINGO-1, transmitting the signal from myelin-derived
inhibitors [28-30]. Rho directly binds p75NTR and this
interaction modulates Rho activity [31,32]. Activation of
Rac by p75NTR induces apoptosis via activation of JNK in
oligodendrocytes [18]. It is possible that up regulation of
three members of the TNF receptor family in the injured
spinal cord is involved in the apoptotic cell death of trans-
planted NSPCs and this process can be modulated by the
activity of Rho GTPases.
Rho GTPases have diverse functions in the neural tissue.
Several lines of evidence indicate that Rho GTPases regu-
late cell survival. Rac/Cdc42 GTPases promote the apop-
totic death of NGF-deprived sympathetic neurons [16,17]
and activation of Rac by p75NTR induces apoptosis via acti-
vation of JNK [18]. These studies suggest negative roles of
Rho family GTPases in cell survival. However, in the case
of cerebellar granule cells, down-regulation of Rac GTPase
induces apoptosis through the c-Jun-dependent induction
of the BH3-only protein Bim and the subsequent activa-
tion of a mitochondrial apoptotic cascade [22]. These pre-
vious reports indicate that the balance between pro-
survival and pro-apoptotic effects of Rho GTPase is cell-
type and context dependent. Our in vitro data indicate
strong effect of Rho GTPase up regulation on the enhance-
ment of an apoptotic cascade after withdrawal of bFGF.
Furthermore, suppression of both Rho and Rac GTPase
activity by DN constructs resulted in strong inhibition of
a mitochondrial apoptotic cascade induced by stau-
rosporine. These observations support the view that acti-
vation of Rho and Rac in NSPCs both in vitro and in the
injured spinal cord accelerates activation of an apoptotic
cascade. DN and CA forms of Rho family GTPase mutants
have been widely used to specifically regulate signaling
pathways mediated by Rho, Rac or Cdc42 [33]. However,
it has also been reported that dominant-negative mutants
of Rho family GTPases compete for the same guanine
nucleotide exchange factors, and therefore their inhibitory
effects do not reflect the phenotype of selective inactiva-
tion [34]. We observed differential effects of three DN
mutants on the survival of transplanted NSPCs in a condi-
tion with a similar level of adenoviral infection, suggest-
Differential responses of NSPCs expressing mutated forms  of Rho GTPases after withdrawal of bFGF Figure 6
Differential responses of NSPCs expressing mutated 
forms of Rho GTPases after withdrawal of bFGF. (A) 
Anti-activated caspase-3 immunostaining of cultured NSPCs 
infected with recombinant adenoviruses expressing mutated 
forms of Rho GTPases. Activated caspase-3 immunoreactiv-
ity was observed in a small fraction of NSPCs (red). Similar 
extent of adenovirus infection was confirmed by immunos-
taining with anti-β-galactosidase antibody (green; CA muta-
tions) or anti-GFP antibody (green; DN mutations). Bar, 20 
μm. (B) Quantification of cells immunopositive with anti-acti-
vated caspase-3. Percentage of immunopositive cells is pre-
sented. There was a significant increase of cell death in cells 
expressing RhoCA (GFP control; 0.9 ± 0.3%, CdcCA; 2.6 ± 
0.5%, CdcDN; 1.5 ± 0.6%, RacCA; 1.9 ± 0.2%, RacDN; 0.5 ± 
0.3%, RhoCA; 8.0 ± 1,1% (ANOVA, p < 0.01), RhoDN; 0.8 ± 
0.3%).Molecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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Effects of suppressing Rho and Rac activity in staurosporine-induced cell death Figure 7
Effects of suppressing Rho and Rac activity in staurosporine-induced cell death. (A) Anti-activated caspase-3 and 
anti-ssDNA immunostaining of cultured NSPCs infected with recombinant adenoviruses expressing both RhoDN and RacDN. 
Higher proportions of anti-activated caspase-3 or ssDNA immunopositive cells (red) were observed in the control condition 
(arrows). Several GFP-negative cells expressed active caspase-3 (arrow heads). Cells were counterstained with Hoechst 33342 
dye to visualize nuclei (blue). Bar, 20 μm. (B) Quantification of immunopositive cells for anti-activated caspase-3 or anti-ssDNA 
antibodies colocalized with GFP. Reduction of immunopositive cells was statistically significant (anti-activated caspase-3; p < 
0.01, anti-ssDNA; p < 0.01, Mann-Whitney test).Molecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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ing pathway-specific effects of these DN mutants. At least,
opposite effects of CdcDN and RacDN on the survival of
transplanted cells can not be explained by non-specific
competition of guanine nucleotide exchange factors by
multiple DN mutants. Negative effect of both CdcDN and
CdcCA on the survival of transplanted cells may reflect the
importance of controlled cycling of Cdc42 between an
active GTP-bound and inactive GDP-bound state for
proper regulation of cell proliferation and survival. This
property is unique to Cdc42 mutants, further supporting
selectivity of individual DN and CA mutants.
Another important function of Rho family GTPases is reg-
ulation of cell motility. In fibroblasts, Rho regulates the
formation of contractile actin-myosin filaments to form
stress fibers, while Rac and Cdc42 regulate lamellipodia
and filopodia formation, respectively [14]. In developing
neurons, Rho activity is important in the growth cone
motility [35,36]. Chemotaxis in a variety of cell types is
regulated by local activation of Rac or Ras, and subse-
quent establishment of a phosphoinositide gradient by
phosphatidylinositol 3'-kinase (PI3K) is also important
[37,38]. In this sense, we expected to see profound effects
of manipulating Rho GTPases on the distribution of trans-
planted cells in the spinal cord. However, there was no
significant difference in the migration pattern of trans-
planted cells along the rostrocaudal axis and also in their
preferential accumulation in the dorsal white matter.
Motile behavior of neural precursor cells during normal
brain development has been studied extensively using
real-time imaging of both slice preparations and in vivo
imaging [39-41]. In turn, characterization of NSPC motil-
ity in the injured tissue environment is not yet fully char-
acterized. A recent report indicates the importance of
chondroitin sulfate proteoglycans (CSPGs) as a putative
negative regulator of NSPC migration [42]. It is not yet
clear, however, if this regulatory effect of CSPGs is medi-
ated by Rho GTPase-dependent signaling pathway.
It is possible that the migration of transplanted NSPCs in
the spinal cord is independent of Rho GTPase activation
and its control on the actin reorganization. In this sense,
the effects of other regulators of actin dynamics on the
migratory behavior of transplanted cells should be
intriguing [38]. It is also important to perform real-time
analysis of cell migration and dynamic morphological
change after transplantation, either by microscope-based
imaging [43] or bioluminescence-based whole body-
imaging [44].
Rho GTPases are also involved in the maintenance of stem
cells and their directed differentiation. In the case of
hematopoietic stem/progenitor cells (HSC/Ps), genetic
deletion of Rac1 in HSC/Ps results in their reduced ability
to reconstitute hematopoiesis in vivo [45-47]. Rac2 null
HSC/Ps displayed different phenotype, indicating distinct
roles of two Rac isoforms in hematopoietic development.
Rac1 is also essential in the maintenance of stem cells in
the epidermis [48]. Conditional knockout of Rac1 in the
epidermis resulted in depletion of stem cell population
and this effect is dependent on negative regulation of c-
Myc activity through p21-activiated kinase 2. Rho activity
is involved in the fate decision of mesenchymal precursor
cells. Mesenchymal precursor cells can differentiate into
both adipocytes and myocytes by stimulation with insu-
lin-like growth factor-1. Activity level of Rho GTPase is a
component of a critical switch in this fate decision [49].
Similar regulatory roles of RhoA have been reported in the
case of fate decision between adipocytes and osteoblasts
from mesenchymal precursors [50]. Do Rho GTPases
influence the maintenance of stem cell state and subse-
quent fate decision in NSPCs? We observed an unaltered
differentiation phenotype of NSPCs expressing Rho
GTPase mutants after transplantation and also after
induction of in vitro differentiation by growth factor with-
drawal. Proliferation of NSPCs in the presence of bFGF
also did not show prominent change by expressing Rho
GTPase mutants. In addition, our previous transplanta-
Enhancement of cell survival in the injured spinal cord by  suppression of Rho and Rac activity Figure 8
Enhancement of cell survival in the injured spinal 
cord by suppression of Rho and Rac activity. (A) Distri-
bution of transplanted stem cells expressing both RhoDN 
and RacDN 7 days after transplantation. Cells expressing 
both RhoDN and RacDN (green) survived in the injured spi-
nal cord (arrow). The sections were stained with anti-neuro-
filament-200 antibody (red). Arrowhead indicates the site of 
transection. Bar, 200 μm. (B) Quantification of cells present 
in the injured spinal cords 7 days after transplantation of 
NSPCs expressing RhoDN and RacDN. There was a signifi-
cant increase of surviving cell numbers after transplantation 
of DN forms of Rho and Rac (control; 179.7 ± 28.6 cells (n = 
6), RhoDN and RacDN; 420.6 ± 72.2 cells (n = 5), t-test p < 
0.01).Molecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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tion experiments in combination with subsequent admin-
istration of 5-Bromo-2-deoxyuridine (BrDU) indicated
that proliferation of NSPCs did not take place in the host
spinal cord [20]. These observations collectively indicate
minimal impacts of manipulating Rho GTPase activity on
proliferation/differentiation of NSPCs after transplanta-
tion.
It has been reported that transplanted neural stem cells
originated from E14 cerebral cortex were differentiated
preferentially into astrocytes in adult intact and injured
spinal cords [51]. They also showed that the number of
differentiated astrocytes increased during the observation
period after injury. In our study, the proportion of astro-
cyte differentiation from the transplanted NSPCs is higher
in the injured than in the intact spinal cords. The injured
environments may provide a field with increased factors
which induce astrocyte differentiation, such as CNTF and
IL-6 [52,53]. Recently, it is also reported that elevation of
both FGF2 and CNTF level after spinal cord injury induces
development of oligodendrocytes [54]. Previously, we
indicated that higher number of transplanted NSPCs dif-
ferentiated into oligodendrocytes expressing RIP or
CNPase in the intact neonatal spinal cords [20]. In embry-
onic and neonatal stages, the Notch-signaling plays an
important role in differentiation of oligodendrocytes
[55]. The transplanted NSPCs can be affected by control-
ling the Notch level under in intact neonatal spinal cords.
These reports may explain our observation that NSPCs
preferentially differentiate into oligodendrocytes in the
intact, but into astrocytes in the injured spinal cords. Arti-
ficially preventing differentiation of transplanted NSPCs
into astrocytes by controlling injured environments may
make more oligodendrocytes which should facilitate
axonal regeneration after spinal cord injury.
Conclusion
In vitro-expanded NSPCs derived from the fetal hippoc-
ampus are ones of the potential sources for transplanta-
tion therapy of the damaged CNS including the spinal
cord. Throughout characterization of both cell-autono-
mous and environmental factors influencing survival,
migration, and differentiation of NSPCs should be critical
in designing the optimal strategy to repair the injured
CNS. Manipulation of factors intrinsic to the NSPCs, such
as the activity of signaling molecules characterized in this
study, is a promising approach, as recent development of
genetic manipulations enabled us to activate or inactivate
individual components of diverse signaling cascades pre-
cisely.
Methods
FGF-responsive NSPC culture
The generation and characterization of embryonic neural
stem cell cultures were described previously [3,20]. In
brief, the hippocampi of E16 embryos from pregnant
Sprague-Dawley rats were dissected in Ca2+- and Mg2+-
free Hanks' Balanced Salt Solution (HBSS) supplemented
with 16 mM Na-HEPES (pH 7.2), and mechanically disso-
ciated. The cells were collected and resuspended in N2
medium [56] and bFGF (10 ng/ml; R&D systems, Minne-
apolis, MN). Cells were grown on a 10-cm plastic dish
precoated with poly-L-ornithine (Sigma, St. Louis, MO)
and fibronectin (Invitrogen, Carlsbad, CA). bFGF was
added daily, and the medium was replaced every 2 days.
Cells were maintained for 7 days after initial plating. The
cells were passaged at 60-70% confluence by brief incuba-
tion in Ca2+- and Mg2+- free HBSS and dislodging with a
cell lifter. To induce staurosporine-dependent apoptosis,
NSPCs passaged once and maintained for additional 4-5
days in the presence of bFGF were exposed to stau-
rosporine (0.25 mM) for 18 h [57].
Recombinant adenoviruses-mediated gene transfer
Recombinant adenoviruses expressing constitutive active
(CA) or dominant negative (DN) forms of Cdc42, Rac1 or
RhoA, together with marker genes (lacZ for CA and GFP
for DN) under the control of a CAG promoter were con-
structed as previously described using Adenovirus Expres-
sion Vector Kit (Code 6150: TaKaRa New York, NY) [58].
Titers of adenoviruses were as follows; Ad-GFP; 5.0 × 109,
Ad-LacZ; 4.3 × 109, cdc CA; G12V2.3 × 1010, cdc DN
T17N; 1.7 × 1010, rac CA G12V; 3.3 × 109, rac DN T17N;
6.76 × 1010, rho CA G14V; 5.1 × 109, rho DN T19N; 6.7 ×
1010 (PFU/ml). NSPCs were infected with concentrated
stocks of adenoviruses after adjustment of their final
PFUs. By using the internal ribosome entry site (IRES)-
based bicistonic vector system, both marker genes and
mutant forms of Rho GTPases were expressed by infection
of single adenoviruses. NSPCs maintained in the presence
of bFGF for 6 days after the initial passage were exposed to
recombinant adenoviruses for 2 days. The cells exposed to
recombinant adenoviruses were washed three times with
HBSS, mechanically dissociated, collected by brief centrif-
ugation and resuspended in N2 medium at a concentra-
tion of 105 cells/μl.
Immunocytochemistry of cultured NSPCs
NSPCs exposed to recombinant adenoviruses containing
lacZ or GFP reporter genes were fixed with 2% paraformal-
dehyde (PFA) in PBS for 30 min. After treatment with
0.2% Triton X-100 for 5 min, cells were blocked with 5%
NGS and incubated with anti-nestin antibody (Develop-
mental Studies Hybridoma Bank, Iowa City, IA). Primary
antibody was visualized with goat anti-mouse IgG conju-
gated to Cy3 (1:200, Jackson ImmunoResearch, West
Grove, PA). LacZ positive cells were subsequently stained
by using rabbit polyclonal anti-β-galactosidase antibody
(ICN, Costa Mesa, CA) and secondary antibody conju-
gated to Alexa 488 (Molecular Probes, Eugene, OR). In theMolecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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experiments where cells were manipulated to induce
apoptotic cell death [57], anti-activated caspase3 anti-
body (Promega, Madison, WI) and anti-single stranded
DNA (ssDNA) antibody (DAKO, Glostrup, Denmark)
were used as the primary antibody and both were visual-
ized with goat anti-rabbit IgG conjugated to Cy3. To eval-
uate effects of adenovirus-mediated expression of CA or
DN forms of Rho family GTPases on differentiation of
NSPCs in vitro, subconfluent NSPCs were exposed to
recombinant adenoviruses, maintained in the presence of
bFGF for two days, and then switched to the differentia-
tion condition without bFGF for the following two days.
The cells were fixed with 2% PFA in PBS, and stained with
microtubule associated protein 2 (MAP2; Sigma), glial
fibrillary acidic protein (GFAP; Sigma), or RIP (Develop-
mental Studies Hybridoma Bank) to determine their dif-
ferentiation phenotype. The quantification of cells was
done by capturing images of cells immunopositive for
neuronal/glial markers, together with Hoechst33342
(Molecular Probes) staining as a nonselective nuclear
marker, in randomly selected five areas within a dish. In
quantitative analysis, 40-121 cells were counted per each
area, with total numbers of cells in the range of 200-644.
More than two independent culture preparations were
analyzed and averaged.
Animals and surgical procedures
The animal care committee of Tokyo Medical and Dental
University approved all animal experiments. Neural pro-
genitor cells expanded in vitro were genetically labeled
with recombinant adenoviruses and grafted into intact or
previously transected spinal cords of 14-day-old rat pups.
For transplantation of NSPCs, animals were cryoanaesthe-
tized and laminectomy (at the level of T9-10 for intact spi-
nal cords and T8-9 for transected spinal cords) was
performed. The dura was cut, and 1 μl of the cell suspen-
sion (105 cells per μl) was gently injected into the right
side of the gray matter using a glass micropipette (tip
diameter; 100 μm) at a depth of less than 1 mm. The glass
micropipette was held in place for 2 min and slowly with-
drawn. Complete transection of the spinal cord at the
level of T9-10 was performed by using an ophthalmic
blade on 7-day-old rat pups. In the data set for the com-
parison of intact and transected spinal cords without
manipulation of Rho family GTPases, we analyzed data
from 6 successful transplantations into injured spinal
cords (6 out of 8 trials), and 8 transplantation into unin-
jured spinal cords (8 out of 10 trials). In the data set for
the short-term manipulation of Rho family GTPase activ-
ity, 80 transplantation experiments were performed on 7-
day-old rat pups with one week interval between trans-
plantation and sample fixation (LacZ: n = 6, GFP: n = 12,
cdcCA: n = 5, cdcDN: n = 11, racCA: n = 12, racDN: n = 11,
rhoCA: n = 10, rhoDN: n = 13). For the analysis of long-
term effects of manipulating Rho family GTPase, the
NSPCs expressing either GFP alone (n = 5) or the combi-
nation of two DN mutants (racDN pus rhoDN; n = 5)
were transplanted into spinal cords of 7-day-old rat pups
and maintained three weeks before analysis.
Immunohistochemistry of transplanted spinal cords
To characterize migration pattern and differentiation of
transplanted NSPCs in the host spinal cord, immunohis-
tochemistry using anti-β-galactosidase antibody or anti-
GFP antibody (mouse monoclonal, gift from Dr. S.
Mitani; rabbit polyclonal, Molecular Probes, Eugene, OR)
was performed. One or three weeks after transplantation,
animals were intracardially perfused by 2% PFA in PBS
under terminal chloral hydrate anesthesia (600 mg/kg
body weight, intraperitoneal injection). In the transplan-
tation experiments without spinal cord transection, the
spinal cords were carefully isolated and processed with
microslicer (Dosaka EM, Kyoto, Japan)to obtain sagittal
or axial sections (50 μm). In the transplantation experi-
ments into the injured spinal cords, fixed spinal cords
were dissected, cryoprotected with sucrose and embedded
in 1% agar with PBS for further processing with a cryostat
to produce sagittal sections (20 μm). Selected sections
were stained by using anti-β-galactosidase or anti-GFP
antibody and secondary antibody conjugated to Alexa
488 for the detection of transplanted cells. To detect colo-
calization with various neural markers, the sections were
further processed by reacting with either anti-MAP2
(Sigma), neurofilament-200 (Sigma), anti-GFAP (Sigma),
anti-CNPase (Sigma), or RIP (Developmental Studies
Hybridoma Bank) antibodies and subsequently incu-
bated with secondary antibodies conjugated to Cy3.
Images were obtained on a Fluoview confocal laser micro-
scope (Olympus, Tokyo, Japan).
Image analysis
To quantitatively evaluate the migratory behavior of trans-
planted cells, we serially sectioned spinal cords and exam-
ined anti-GFP- or anti-β-galactosidase immunopositive
cells by fluorescence microscope with a low magnification
objective lens (X10). We selected a single section that con-
tained the highest number of GFP- or β-galactosidase-pos-
itive cells. In experiments of survival of GFP-positive
control cells and RacDN/RhoDN double positive cells, we
analyzed the complete sets of serial sections. Each 500 μm
segment was examined with a high magnification objec-
tive lens (X60) to identify single cells and their number
per segment. Only GFP- or β-galactosidase positive cells
which showed simultaneous labeling of nuclei with
Hoechst nuclear dye were counted. This procedure
reduces the possibility of double counting same cells in
adjacent sections. We first calculated the sum of cell num-
bers in 500 μm segments to obtain total number of cells
per microslicer section and then summed the total
number of cells per section to obtain the total number ofMolecular Brain 2009, 2:37 http://www.molecularbrain.com/content/2/1/37
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transplanted cells per spinal cord. As we did not attempt
to incorporate stereological techniques, sampling bias is
likely to be present in cell number estimation. However,
this sampling bias will affect the cell number estimation
of transplanted cells both in control and manipulated spi-
nal cords proportionally. Therefore we did not attempt to
incorporated stereological techniques to obtain corrected
total number of transplanted cells.
In experiments of evaluating migratory behavior of trans-
planted cells, we selected a single section which contained
the highest number of GFP- or β-galactosidase-immunop-
ositive cells among serial sections. In most cases, align-
ment of sections with the rostrocaudal axis was good
enough to hold both the most rostral and caudal part of
the spinal cord where transplanted cells existed. When the
alignment of sections was not good enough to reveal the
entire profile of cell distribution in a single section, these
samples were excluded from the analysis. In experiments
with normal spinal cords, the position of needle place-
ment was identified by the presence of scar tissue and this
position (injection site) was set to the center of initial 500
μm segment (Figure 5A). In experiments with injured spi-
nal cords, the position of spinal cord transection was also
recorded in addition to the injection site. Toward both
rostral and caudal part of the spinal cord, multiple 500
μm segments were set sequentially, with the initial seg-
ment at the injection site as a reference of the central seg-
ment. GFP- or β-galactosidase-immunopositive cells were
detected by using a high magnification objective lens
(X60) and their total number per segment and the num-
bers of cells in either the dorsal white matter or the gray
matter were counted. The average migratory distance of
transplanted cells (L) in individual sections of the spinal
cord was calculated by using the following equation;
Where n = number of cells present in each 500 μm seg-
ment, y = distance of the center of each segment from the
injection site, N = total cell number present in the section.
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